Search results
Results from the WOW.Com Content Network
Fortune 500 companies based in Houston [1]: Rank Company name 7: ExxonMobil: 15: Chevron: 26: Phillips 66: 54: Sysco: 90: Enterprise Products Partners: 92: Plains GP ...
ACG is the world’s largest integrated supplier of solid dosage products and services. [2] ACG provides empty hard pharmaceutical capsules, [3] encapsulation machinery, tablet coating systems, tablet compression systems, fluid bed equipment, tablet tooling, and performance enhancers along with online and inline analytical and inspection systems.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.
CDI Corporation is a privately held US company providing engineering, procurement, construction management and staffing services to clients in a range of industries including energy, chemical, semiconductor and battery manufacturing.
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. [1] Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.
In August 2004, the company prevailed in a patent case by Teva Pharmaceutical Industries related to Sarafem . [5] On May 19, 2006, the company received approval from the Food and Drug Administration for Sarafem. [6] On October 30, 2009, the company acquired the prescription drug business of Procter & Gamble for $3.1 billion. [7]